Cambridge Cognition Holdings (LSE:COG) Growth Rank: 5 (As of Aug. 11, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:COG Cambridge Cognition Holdings PLC LSE:COG
47 GF Score
Price £0.33
GF Value £0.33
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cambridge Cognition Holdings Growth Rank?

Cambridge Cognition Holdings LSE:COG 47 Growth Rank is 5 as of Aug. 11, 2026, which is at its 10-year median of 5.00. GuruFocus rates LSE:COG with a GF Score™ of 47/100 and a GF Value™ of £0.33 (Fairly Valued). The stock has 5 warning signs investors should review.

Cambridge Cognition Holdings has the Growth Rank of 5.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Cambridge Cognition Holdings Growth Rank Related Terms

LSE:COG vs VEEV, BTSG, HQY: Growth Rank Comparison

For the Health Information Services subindustry, Cambridge Cognition Holdings's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cambridge Cognition Holdings Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cambridge Cognition Holdings's Growth Rank distribution charts can be found below:

* The bar in red indicates where Cambridge Cognition Holdings's Growth Rank falls into.


LSE:COG
47GF Score
Cambridge Cognition Holdings PLC LSE:COG
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 5 mean?
Cambridge Cognition Holdings (LSE:COG) has a Growth Rank of 5 as of Aug. 11, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Cambridge Cognition Holdings and its competitors. This is near median its historical median of 5.00. Over the past decade, Cambridge Cognition Holdings' Growth Rank has ranged from 1.00 to 8.00.
Is Cambridge Cognition Holdings' Growth Rank too high?
Cambridge Cognition Holdings' current Growth Rank of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 8.00. Overall, Cambridge Cognition Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cambridge Cognition Holdings' Growth Rank compare to VEEV and BTSG?
Cambridge Cognition Holdings' Growth Rank of 5 can be compared against companies in the Healthcare Providers & Services industry. Historically, Cambridge Cognition Holdings' own Growth Rank has ranged from 1.00 to 8.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Cambridge Cognition Holdings and its competitors. Cambridge Cognition Holdings's current Growth Rank is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Cognition Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Cognition Holdings (LSE:COG) is currently considered Fairly Valued. The stock's GF Value™ is £0.33, compared to a current price of £0.33 — trading right at its estimated fair value. The current Growth Rank is 5, which is near median its 10-year median of 5.00. Cambridge Cognition Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Cambridge Cognition Holdings (LSE:COG), the current Growth Rank is 5 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cambridge Cognition Holdings (LSE:COG) Overvalued in 2026?

Based on GuruFocus' analysis, Cambridge Cognition Holdings stock appears to be undervalued. The current stock price of £0.33 is trading 0% below its estimated GF Value™ of £0.33. GuruFocus considers Cambridge Cognition Holdings to be Fairly Valued.

Key valuation signals for LSE:COG:

  • Growth Rank: 5 (near median its 10-year median of 5.00)
  • GF Value™: £0.33 vs. price of £0.33 (0% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the LSE:COG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cambridge Cognition Holdings Business Description

Other Exchanges 1M7:Germany
Address Tunbridge Lane, Tunbridge Court, Bottisham, Cambridge, GBR, CB25 9TU
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the measurement of clinical outcomes in neurological disorders. It develops and commercialises neuroscience technologies to assess cognitive function for sale across the world. The company's products include CANTAB web-based assessments, Electronic questionnaires and scales (eCOA), NeuroVocalix Winterlight, a voice analysis tool to assess cognitive changes, high-frequency testing kits, and Clinpal, among others. Its operating segments are: Clinical studies, which generate maximum revenue, Academic research, Professional Healthcare, and Consumer Health & Wellness. Geographically, the company generates maximum revenue from the USA, and the rest from the UK, the European Union, and the Rest of the world.
47GF Score

Get the complete analysis for LSE:COG

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.33
Price
£0.33
GF Value